RT @ericdeinmd: #EULAR2022 ASAS/EULAR AxSpA Recs âï¸Last: 2016 â¶ï¸All: education, exercise, ð â¶ï¸âcsDMARD
Tweet Content
#EULAR2022 ASAS/EULAR AxSpA Recs
⭐️Last: 2016
▶️All: education, exercise, 🚭
▶️❌csDMARD for axial disease
▶️TNF/IL17 (or JAK) with high disease: ASDAS>/=2.1
▶️Monoclonal TNF for uveitis/IBD, high PsO: IL-17
▶️Sustained remission: tapering of bDMARD "can be considered"
@RheumNow https://t.co/3yYU0Vb37r
Show on Archive Page
On
Display in Search Results
On
PDQ
Off